4 (pyrrolopyridinyl)pyrimidin-2-ylamine derivatives

A method for treating a tumour, comprising administering to a subject in need thereof an effective amount of a compounds of formula I

• in which
• R1 denotes H, A, —[C(R6)2]nAr, —[C(R6)2]nHet or —[C(R6)2]ncycloalkyl,
• R2 denotes H or A,
• R3, R4 each, independently of one another, denote H, A, Hal, CN, —[C(R6)2]nAr, —[C(R6)2]nHet or -[C(R6)2]ncycloalkyl,
• R5 denotes H, A, —[C(R6)2]nAr, —[C(R6)2]nHet or —[C(R6)2]ncycloalkyl,
• R6 denotes H or alkyl having 1-6 C atoms,
• A, A′ each, independently of one another, denote unbranched or branched alkyl having 1-10 C atoms, in which one or two CH2 groups may be replaced by O or S atoms and/or by —CH═CH— groups, and/or 1-7 H atoms may be replaced by F,
• Hal denotes F, Cl, Br or I,
• Ar denotes a saturated, unsaturated or aromatic carbocycle having 5-14 C atoms which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by OH, OA, SH, SA, SOA, SO2A, Hal, NO2, NH2, NHA, NAA′, A, SO2NH2, SO2NHA, SO2NAA′, CONH2, CONHA, CONAA′, NACOA′, NASO2A′, COOH, COOA, COA, CHO and/or CN,
• Het denotes furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyrimidinyl, triazolyl, tetrazolyl, thiadiazole, pyridazinyl, pyrazinyl, indolyl, isoindolyl, benzimidazolyl, indazolyl, quinolyl or 1,3-benzodioxolyl, each of which is unsubstituted or mono- or disubstituted by OH, OA, Hal and/or A, and
• n denotes 0, 1 or 2,
• or a pharmaceutically acceptable derivative, solvate, salt, tautomer or stereoisomer thereof.